Our analysts think Merck $MRK is an appealing investment opportunity in drug manufacturing. The combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. https://t.co/ajQ3W42ycA https://t.co/o1KF2PmPvh